Publications

Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

International Generic Pharmaceutical Alliance (IGPA) Letter Regarding TGA Guidance Titled “Evaluation of Biosimilars”, 2013

18 September 2013

Policy

Open

Safe Prescription,Safe Dispensing, Identification and Track&Trace of All Biologicals in the Context of the Re-opened Biosimilars INN Debate – 11th EGA Symposium on Biosimilar Medicines, Suzette Kox, London 2013

25 April 2013

Policy

Open

Biosimilar Monoclonal Antibodies – 11th EGA International Symposium on Biosimilar Medicines, Gudbjorg Edda Eggertsdottir, London, 25 April 2013

25 April 2013

Policy

Open

Production and Control of Biosimilars versus Innovators, Biosimilars Present and Future – Da Silva, Infarmed, Lisbon, 3 April 2013 (PPT)

3 April 2013

Policy

Open

KPMG Report: Advice on the implementation of EU-Directive 2011/62/EU

22 February 2013

Report

According to the European Commission (hereinafter ‘EC’) of the European […]

Read more

Emergence of Biosimilar Medicines – The Biosimilar Company Point of View, Paul Greenland, Belgium Federal Parliament, Brussels, 22 November 2012 (PPT)

22 November 2012

Policy

Open

EMA Questions and Answers on Biosimilar Medicines (Similar Biological Medicinal Products)

27 September 2012

Policy

Open

EGA Q&A on the Revised EMA Bioequivalence Requirement

22 June 2010

Report

Open

Generic Medicines: Essential Contributor to the Long-Term Health of Society

21 March 2010

Report

Open

Patent-Related Barriers to Market Entry for Generic Medicines in the European Union

30 June 2009

Report

Open

Subscribe to our newsletter